As clinical NGS testing volumes grow in response to expanded medical knowledge, new targeted therapy approvals, the commercial availability of large comprehensive gene panels, and favorable coverage decisions, the challenge of quality clinical interpretation and variant classification will also grow.
This technical note from Velsera describes the Velsera Knowledgebase, a component of the Clinical Genomics Workspace that enables users to classify and interpret variants to produce an actionable report, in the context of somatic cancer biomarker reporting.
Offered Free by: Velsera
See All Resources from: Velsera